Matches in Wikidata for { <http://www.wikidata.org/entity/Q61918139> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q61918139 description "assaig clínic" @default.
- Q61918139 description "clinical trial" @default.
- Q61918139 description "clinical trial" @default.
- Q61918139 description "clinical trial" @default.
- Q61918139 description "clinical trial" @default.
- Q61918139 description "ensaio clínico" @default.
- Q61918139 description "ensayo clínico" @default.
- Q61918139 description "ensayu clínicu" @default.
- Q61918139 description "essai clinique" @default.
- Q61918139 description "klinisch onderzoek" @default.
- Q61918139 description "клінічне випробування" @default.
- Q61918139 name "Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis" @default.
- Q61918139 type Item @default.
- Q61918139 label "Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis" @default.
- Q61918139 prefLabel "Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis" @default.
- Q61918139 P1050 Q61918139-A4EC67B1-B176-487D-A75E-60127F19CE95 @default.
- Q61918139 P1050 Q61918139-BCF8E6FE-485A-4F9F-9269-F66E84AF8B9A @default.
- Q61918139 P1132 Q61918139-68F15D5B-E491-4B80-87BF-EEE78E72DD3E @default.
- Q61918139 P1476 Q61918139-BF9A3530-D848-4B48-BE54-97A2DA2F9268 @default.
- Q61918139 P17 Q61918139-01CB672C-0C90-48CB-8DF3-A5B3FD3D94EF @default.
- Q61918139 P17 Q61918139-17608E22-DB37-4F3C-897B-8105B5C44BBC @default.
- Q61918139 P17 Q61918139-326C4426-6AA5-466B-8CBE-A8AB945031D1 @default.
- Q61918139 P17 Q61918139-5837EA84-6F44-4921-8F63-36389D44DD4C @default.
- Q61918139 P17 Q61918139-E690746E-0CBB-447C-A40A-5775656BD903 @default.
- Q61918139 P2899 Q61918139-294F8C0B-4287-40D9-9290-BFFDA20CD5C3 @default.
- Q61918139 P3098 Q61918139-42905D8D-C5E2-4F5E-A2F9-19F50A46BE35 @default.
- Q61918139 P31 Q61918139-04A0F00F-AF61-445E-A7DC-1A6216D7A22D @default.
- Q61918139 P4135 Q61918139-9A49ED75-466E-4128-BDBC-521AB5AB71C5 @default.
- Q61918139 P4844 Q61918139-7D41A86A-60F9-456F-ABC8-C477B6F5122E @default.
- Q61918139 P580 Q61918139-92488C56-D9DE-459C-A863-3FA70B8D564A @default.
- Q61918139 P582 Q61918139-B6E2CBE2-126A-40E5-AE07-2A788213A4CE @default.
- Q61918139 P6099 Q61918139-A71D2EFA-3C1B-4232-A3CC-7F29DF23528F @default.
- Q61918139 P6153 Q61918139-9A5C9DCD-AA4D-45AB-ACA2-81C8E174CD98 @default.
- Q61918139 P8363 Q61918139-74AB737D-F00C-403C-96D1-04A539061993 @default.
- Q61918139 P859 Q61918139-A2C25682-FEE7-4A75-B38A-6AA64A1CBC4D @default.
- Q61918139 P1050 Q140067 @default.
- Q61918139 P1050 Q8277 @default.
- Q61918139 P1132 "+118" @default.
- Q61918139 P1476 "A Randomized, Multinational, Double-Blind, Placebo-Controlled, Parallel-Group Design Pilot Study to Estimate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamic Effects of Teriflunomide for 24 Weeks When Added to Treatment With Interferon-beta in Subjects With Multiple Sclerosis." @default.
- Q61918139 P17 Q16 @default.
- Q61918139 P17 Q183 @default.
- Q61918139 P17 Q29 @default.
- Q61918139 P17 Q30 @default.
- Q61918139 P17 Q38 @default.
- Q61918139 P2899 "+18" @default.
- Q61918139 P3098 "NCT00489489" @default.
- Q61918139 P31 Q30612 @default.
- Q61918139 P4135 "+55" @default.
- Q61918139 P4844 Q2450337 @default.
- Q61918139 P580 "2007-05-01T00:00:00Z" @default.
- Q61918139 P582 "2009-06-01T00:00:00Z" @default.
- Q61918139 P6099 Q42824440 @default.
- Q61918139 P6153 Q158205 @default.
- Q61918139 P8363 Q78089383 @default.
- Q61918139 P859 Q158205 @default.